Anderson DE, Islam A, Crameri G, Todd S, Islam A, Khan SU, Foord A, Rahman MZ, Mendenhall IH, Luby SP, Gurley ES, Daszak P, Epstein JH, Wang LF

Isolation and Full-Genome Characterization of Nipah Viruses from Bats, Bangladesh

Emerg Infect Dis, 2019; 25(1): 166-170. 10.3201/eid2501.180267
Carstensen LS, Tamason CC, Sultana R, Tulsiani SM, Phelps MD, Gurley ES, Jensen PKM

The Cholera Phone: Diarrheal Disease Surveillance by Mobile Phone in Bangladesh

Am J Trop Med Hyg, 2019; 100(3): 510-516. 10.4269/ajtmh.18-0546
Haque F, Rahman M, Banu NN, Sharif AR, Jubayer S, Shamsuzzaman A, Alamgir A, Erasmus JH, Guzman H, Forrester N, Luby SP, Gurley ES.

An epidemic of chikungunya in northwestern Bangladesh in 2011

PLoS One, 2019; 14(3): e0212218. 10.1371/journal.pone.0212218
Salje H, Paul KK, Paul R, Rodriguez-Barraquer I, Rahman Z, Alam MS, Rahman M, Al-Amin HM, Heffelfinger J, Gurley E

Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates

Elife, 2019; : pii: e428. 10.7554/eLife.42869
Hegde ST, Salje H, Sazzad HMS, Hossain MJ, Rahman M, Daszak P, Klena JD, Nichol ST, Luby SP, Gurley ES

Using healthcare-seeking behaviour to estimate the number of Nipah outbreaks missed by hospital-based surveillance in Bangladesh

Int J Epidemiol, 2019; : pii: dyz05. 10.1093/ije/dyz057
Zlojutro A, Rey D, Gardner L

A decision-support framework to optimize border control for global outbreak mitigation

Sci Rep, 2019; 9(1): 2216. 10.1038/s41598-019-38665-w
Xu Y, Laeyendecker O, Wang R

Cross-sectional HIV Incidence Estimation Accounting for Heterogeneity Across Communities

Biometrics, 2019; : . 10.1111/biom.13046
Rose R, Rodriguez C, Dollar JJ, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O

Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks

Infect Genet Evol, 2019; 71: 1-6. 10.1016/j.meegid.2019.02.025
Ratmann O, Grabowski MK, Hall M, Golubchik T, Wymant C, Abeler-Dörner L, Bonsall D, Hoppe A, Brown AL, de Oliveira T, Gall A, Kellam P, Pillay D, Kagaayi J, Kigozi G, Quinn TC, Wawer MJ, Laeyendecker O, Serwadda D, Gray RH, Fraser C; PANGEA Consortium and Rakai Health Sciences Program.

Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis

Nat Commun, 2019; 10(1): 1411. 10.1038/s41467-019-09139-4
Sharma S, Schlusser KE, Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, Neaton JD, Laeyendecker O; INSIGHT START Study Group.

The benefit of immediate compared to deferred ART on CD4+ Cell count recovery in early HIV infection

AIDS, 2019; : . 10.1097/QAD.0000000000002219
Solomon SS, Solomon S, McFall AM, Srikrishnan AK, Anand S, Verma V, Vasudevan CK, Balakrishnan P, Ogburn EL, Moulton LH, Kumar MS, Sachdeva KS, Laeyendecker O, Celentano DD, Lucas GM, Mehta SH; Indian National Collaboration on AIDS Study.

Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial

Lancet HIV, 2019; : . 10.1016/S2352-3018(19)30034-7
Houben RMGJ, Lalli M, Kranzer K, Menzies NA, Schumacher SG, Dowdy DW

What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis

Clin Infect Dis, 2019; 68(1): 150-156. 10.1093/cid/ciy544
Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, Atuhumuza E, Nakaye M, Armstrong DT, Dowdy DW, McCulloch CE, Kamya M, Cattamanchi A

Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV

Am J Respir Crit Care Med, 2019; 199(5): 643-650. 10.1164/rccm.201803-0490OC
Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T

Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings

Lancet Infect Dis, 2019; 19(3): e89-e95. 10.1016/S1473-3099(18)30443-2
Dowdy DW

Xpert at 8 years: where are we now, and what should we do next?

J Tuberc Lung Dis, 2019; 23(1): 3-4. 10.5588/ijtld.18.0717
Yoon C, Dowdy DW, Esmail H, MacPherson P, Schumacher SG

Screening for tuberculosis: time to move beyond symptoms.

Lancet Respir Med, 2019; 7(3): 202-204. 10.1016/S2213-2600(19)30039-6
Kasaie P, Schumacher CM, Jennings JM, Berry SA, Tuddenham SA, Shah MS, Rosenberg ES, Hoover KW, Gift TL, Chesson H, German D, Dowdy DW

Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study

BMJ, 2019; 9(3): e023453. 10.1136/bmjopen-2018-023453
Chaisson LH, Semitala FC, Asege L, Mwebe S, Katende J, Nakaye M, Andama AO, Marquez C, Atuhumuza E, Kamya M, Cattamanchi A, Yoon C

Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy

AIDS, 2019; : . 10.1097/QAD.0000000000002130
Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT

Estimating cholera incidence with cross-sectional serology

Sci Transl Med, 2019; 11(480): eaau6242. 10.1126/scitranslmed.aau6242
Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML

Genomic insights into the 2016-2017 cholera epidemic in Yemen

Nature, 2019; 565(7738): 230-233. 10.1038/s41586-018-0818-3
Kendall EA, Azman AS, Maartens G, Boulle A, Wilkinson RJ, Dowdy DW, Rangaka MX

Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting

AIDS, 2019; 33(3): 525-536. 10.1097/QAD.0000000000002053
Omondi FH, Chandrarathna S, Mujib S, Brumme CJ, Jin SW, Sudderuddin H, Miller R, Rahimi A, Laeyendecker O, Bonner P, Yue FY, Benko E, Kovacs CM, Brockman MA, Ostrowski M, Brumme ZL.

HIV subtype and Nef-mediated immune evasion function correlate with viral reservoir size in early-treated individuals

J Virol, 2019; : JVI.01832. 10.1128/JVI.01832-18
Laeyendecker O, Gray RH, Grabowski MK, Reynolds SJ, Ndyanabo A, Ssekasanvu J, Fernandez RE, Wawer MJ, Serwadda D, Quinn TC

Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.

AIDS Res Hum Retroviruses, 2019; : . 10.1089/AID.2018.0207
Winter AK, Martinez ME, Cutts FT, Moss WJ, Ferrari M, McKee A, Lessler J, Hayford K, Wallinga J, Metcalf CJE

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

J Infect Dis, 2018; 218(3): 355-364. 10.1093/infdis/jiy137
Salje H, Cummings DAT,, Rodriguez-Barraquer I, Katzelnick LC, Lessler J, Klungthong C, Thaisomboonsuk B, Nisalak A, Weg A, Ellison D, Macareo L, Yoon IK, Jarman R, Thomas S, Rothman AL, Endy T, Cauchemez S

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk

Nature, 2018; 557(7707): 719-723. 10.1038/s41586-018-0157-4
Finger F, Bertuzzo E, Luquero FJ, Naibei N, Touré B, Allan M, Porten K, Lessler J, Rinaldo A, Azman AS

The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study

PLoS Med, 2018; 15(2): e1002509. 10.1371/journal.pmed.1002509
Reich NG, Lessler J, Varma JK, Vora NM

Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases

Sci Rep, 2018; 8(1): 1093. 10.1038/s41598-018-19406-x
Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Nilsen K, Takahashi S, Metcalf C, Lessler J, Tatem AJ

A spatial regression model for the disaggregation of areal unit based data to high-resolution grids with application to vaccination coverage mapping

Stat Methods Med Res, 2018; : . 10.1177/0962280218797362
Gardner LM, Bóta A, Gangavarapu K, Kraemer MUG, Grubaugh ND

Inferring the risk factors behind the geographical spread and transmission of Zika in the Americas

PLoS Negl Trop Dis, 2018; 12(1): e0006194. 10.1371/journal.pntd.0006194
Morrison D, Laeyendecker O, Konikoff J, Brookmeyer R

Cross-Sectional HIV Incidence Estimation with Missing Biomarkers

Stat Commun Infect Dis, 2018; 10(1): pii: 20170. 10.1515/scid-2017-0003
Ngwira LG, Corbett EL, Khundi M, Barnes GL, Nkhoma A, Murowa M, Cohn S, Moulton LH, Chaisson RE, Dowdy DW

Screening for tuberculosis with Xpert MTB/RIF versus fluorescent microscopy among adults newly diagnosed with HIV in rural Malawi: a cluster randomized trial (CHEPETSA)

Clin Infect Dis, 2018; : . 10.1093/cid/ciy590
Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RM, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW

The Importance of Heterogeneity to the Epidemiology of Tuberculosis

Clin Infect Dis, 2018; : . doi: 10.1093/cid/ciy938
Cherng ST, Shrestha S, Reynolds S, Hill AN, Marks SM, Kelly J, Dowdy DW

Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas

Am J Public Health, 2018; 108(S4): S311-S314. 10.2105/AJPH.2018.304503
Kasaie P, Radford M, Kapoor S, Jung Y, Hernandez Novoa B, Dowdy D, Shah M

Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain

PLoS One, 2018; 13(11): e0206755. 10.1371/journal.pone.0206755
Dodd PJ, Pennington JJ, Bronner Murrison L, Dowdy DW

Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation

Med Decis Making, 2018; 38(8): 930-941. 10.1177/0272989X18807438
Kim HY, Dowdy DW, Martinson NA, Kerrigan D, Tudor C, Golub J, Bridges JFP, Hanrahan CF

Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment

AIDS Behav, 2018; : . 10.1007/s10461-018-2324-x
Kim HY, Hanrahan CF, Martinson N, Golub JE, Dowdy DW

Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa

Int J Tuberc Lung Dis, 2018; 22(12): 1435-1442. 10.5588/ijtld.18.0370
Ciglenecki I, Azman AS, Jamet C, Serafini M, Luquero FJ, Cabrol JC

Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience.

J Infect Dis, 2018; 218(suppl_3): S165-S166. 10.1093/infdis/jiy487
Kapata N, Sinyange N, Mazaba ML, Musonda K, Hamoonga R, Kapina M, Zyambo K, Malambo W, Yard E, Riggs M, Narra R, Murphy J, Brunkard J, Azman AS, Monze N, Malama K, Mulwanda J, Mukonka VM

A Multisectoral Emergency Response Approach to a Cholera Outbreak in Zambia: October 2017-February 2018.

J Infect Dis, 2018; 218(suppl_3): S181-S183. 10.1093/infdis/jiy490
Mwaba J, Ferreras E, Chizema-Kawesa E, Mwimbe D, Tafirenyika F, Rauzier J, Blake A, Rakesh A, Poncin M, Stoitsova S, Kwenda G, Azman AS, Chewe O, Serafini M, Lukwesa-Musyani C, Cohuet S, Quilici ML, Luquero FJ, Page AL.

Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, Zambia.

Trop Med Int Health, 2018; 23(8): 834-840. 10.1111/tmi.13084